Erythropoiesis-stimulating agents (ESAs)
Title
Date Published
Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit.
September 1, 2006
Preoperative Epoetin Alfa vs Autologous Blood Donation in Primary Total Knee Arthroplasty.
August 1, 2006
Cardiovascular effects of erythropoietin: anemia and beyond.
July 31, 2006
Darbepoetin alfa: a review of its use in the treatment of anaemia in patients with cancer receiving chemotherapy.
June 30, 2006
Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.
June 30, 2006
The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life.
June 30, 2006
Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis.
May 31, 2006
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
May 17, 2006
Alternatives to blood product transfusion in the critically ill: Erythropoietin.
May 1, 2006
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial*
April 4, 2006
Managing erythropoietin hyporesponsiveness.
March 31, 2006
Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.
March 1, 2006
Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer.
March 1, 2006
Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.
February 23, 2006
Epoetin beta in oncology: examining the current evidence.
February 1, 2006
Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.
January 31, 2006
The role of erythropoietin therapy in the critically ill.
January 1, 2006
Treatment of Chemotherapy-Induced Anemia in Breast Cancer: Results of a Randomized Controlled Trial of Darbepoetin Alfa 200 mug Every 2 Weeks Versus Epoetin Alfa 40,000 U Weekly.
December 1, 2005
Recombinant human erythropoietin in a triplet pregnancy: a case report.
November 1, 2005
Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice.
October 1, 2005